Canada · Delayed Price · Currency is CAD 2seventy bio Statistics
Total Valuation
CareRx has a market cap or net worth of CAD 180.36 million. The enterprise value is 253.54 million.
| Market Cap | 180.36M |
| Enterprise Value | 253.54M |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CareRx has 63.06 million shares outstanding. The number of shares has increased by 4.11% in one year.
| Current Share Class | 63.06M |
| Shares Outstanding | 63.06M |
| Shares Change (YoY) | +4.11% |
| Shares Change (QoQ) | -0.33% |
| Owned by Insiders (%) | 1.87% |
| Owned by Institutions (%) | 36.97% |
| Float | 29.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.46 |
| PS Ratio | 0.49 |
| PB Ratio | 2.07 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.35 |
| P/OCF Ratio | 5.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.19, with an EV/FCF ratio of 10.33.
| EV / Earnings | -139.54 |
| EV / Sales | 0.69 |
| EV / EBITDA | 10.19 |
| EV / EBIT | 31.43 |
| EV / FCF | 10.33 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.94.
| Current Ratio | 1.08 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 3.29 |
| Debt / FCF | 3.33 |
| Interest Coverage | 1.06 |
Financial Efficiency
Return on equity (ROE) is -2.17% and return on invested capital (ROIC) is 2.98%.
| Return on Equity (ROE) | -2.17% |
| Return on Assets (ROA) | 2.31% |
| Return on Invested Capital (ROIC) | 2.98% |
| Return on Capital Employed (ROCE) | 4.99% |
| Revenue Per Employee | 249,630 |
| Profits Per Employee | -1,239 |
| Employee Count | 1,508 |
| Asset Turnover | 1.68 |
| Inventory Turnover | 14.80 |
Taxes
In the past 12 months, CareRx has paid 32,000 in taxes.
| Income Tax | 32,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.83% in the last 52 weeks. The beta is 0.53, so CareRx's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +28.83% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 2.50 |
| Relative Strength Index (RSI) | 47.03 |
| Average Volume (20 Days) | 68,203 |
Short Selling Information
The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 865 |
| Short Previous Month | 1,548 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CareRx had revenue of CAD 365.96 million and -1.82 million in losses. Loss per share was -0.03.
| Revenue | 365.96M |
| Gross Profit | 108.09M |
| Operating Income | 8.07M |
| Pretax Income | -1.79M |
| Net Income | -1.82M |
| EBITDA | 20.38M |
| EBIT | 8.07M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 8.69 million in cash and 81.87 million in debt, giving a net cash position of -73.18 million or -1.16 per share.
| Cash & Cash Equivalents | 8.69M |
| Total Debt | 81.87M |
| Net Cash | -73.18M |
| Net Cash Per Share | -1.16 |
| Equity (Book Value) | 86.95M |
| Book Value Per Share | 1.38 |
| Working Capital | 4.63M |
Cash Flow
In the last 12 months, operating cash flow was 31.78 million and capital expenditures -7.23 million, giving a free cash flow of 24.55 million.
| Operating Cash Flow | 31.78M |
| Capital Expenditures | -7.23M |
| Free Cash Flow | 24.55M |
| FCF Per Share | 0.39 |
Margins
Gross margin is 29.54%, with operating and profit margins of 2.20% and -0.50%.
| Gross Margin | 29.54% |
| Operating Margin | 2.20% |
| Pretax Margin | -0.49% |
| Profit Margin | -0.50% |
| EBITDA Margin | 5.57% |
| EBIT Margin | 2.20% |
| FCF Margin | 6.71% |
Dividends & Yields
CareRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.11% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.01% |
| FCF Yield | 13.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
CareRx has an Altman Z-Score of 0.64 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.64 |
| Piotroski F-Score | 7 |